Northwest Bioth Cmn (NWBO): Price and Financial Metrics
Northwest Bioth Cmn (NWBO)
Today's Latest Price: $0.34 USD
0.01 (-2.02%)
Updated May 29 5:20pm
Add NWBO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NWBO Stock Summary
- NWBO's price/sales ratio is 91.52; that's higher than the P/S ratio of 97.42% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -0.28 for Northwest Biotherapeutics Inc; that's greater than it is for just 6.44% of US stocks.
- As for revenue growth, note that NWBO's revenue has grown 484.95% over the past 12 months; that beats the revenue growth of 98.64% of US companies in our set.
- Stocks that are quantitatively similar to NWBO, based on their financial statements, market capitalization, and price volatility, are XERS, KPTI, ACUR, ATNX, and INSM.
- Visit NWBO's SEC page to see the company's official filings. To visit the company's web site, go to www.nwbio.com.
NWBO Daily Price Range
NWBO 52-Week Price Range
NWBO Stock Price Chart More Charts
NWBO Price/Volume Stats
| Current price | $0.34 | 52-week high | $0.42 |
| Prev. close | $0.35 | 52-week low | $0.14 |
| Day low | $0.32 | Volume | 2,800,499 |
| Day high | $0.36 | Avg. volume | 2,032,267 |
| 50-day MA | $0.19 | Dividend yield | N/A |
| 200-day MA | $0.21 | Market Cap | 234.33M |
Northwest Bioth Cmn (NWBO) Company Bio
Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies. The company was founded in 1996 and is based in Bethesda, Maryland.
Loading social stream, please wait...